Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1 Other solid neoplasm 1

Conditions

Prostatic Neoplasms 4 Carcinoma, Renal Cell 4 Recurrence 1 Prostatic Hyperplasia 1 Ovarian Neoplasms 1 Neoplasms 1 Neoplasm Metastasis 1 Mesothelioma 1 Kidney Neoplasms 1 Fallopian Tube Neoplasms 1 Colorectal Neoplasms 1

Interventions

Pemetrexed 39 Cisplatin 33 pembrolizumab 21 Nivolumab 17 Carboplatin 16 Ipilimumab 13 Gemcitabine 10 Cyclophosphamide 9 fludarabine 6 durvalumab 6 Bevacizumab 6 Radiotherapy, Intensity-Modulated 4 LMB-100 4 Dexamethasone 4 tremelimumab 3 tazemetostat 3 spartalizumab 3 olaparib 3 niraparib 3 atezolizumab 3 anetumab ravtansine 3 amatuximab 3 Vinorelbine 3 Paclitaxel 3 Imatinib Mesylate 3 Cerebral Decortication 3 tislelizumab 2 sargramostim 2 fludarabine phosphate 2 defactinib 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Mesothelioma × TroVax × Clear all

NCT01569919 2013-03-12

SKOPOS

Wales Cancer Trials Unit

Phase 2 Unknown

Other solid neoplasmThoracic

Mesothelioma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡